UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: April 2, 2024
Accession Number: 0001213900-24-027522
Submission Type: POS AM
CIK: 0001841330
Company Name: Pasithea Therapeutics Corp.
File Number: 333-271011